• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Dihydropyrimidinase-related protein 4 (DPYSL4)

ACP21652

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP21652 Target NameDPYSL4
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range1-572Protein LengthFull length protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDO14531
Background Information
  • Uniprot Id

    O14531

  • Target Species

    Human

  • Target Name

    DPYSL4

  • Target Full Name

    Dihydropyrimidinase-related protein 4

  • Target Function

    Necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. Plays a role in axon guidance, neuronal growth cone collapse and cell migration.

  • Target Subcellular Location

    Cytoplasm.

  • Target Protein Families

    Metallo-dependent hydrolases superfamily, Hydantoinase/dihydropyrimidinase family

  • Target Research Area

    Neuroscience

  • Target Synonyms

    Collapsin response mediator protein 3; CRMP 3; CRMP-3; CRMP3; Dihydropyrimidinase like 4; Dihydropyrimidinase related protein 4; Dihydropyrimidinase-related protein 4; DPYL4_HUMAN; DPYSL4; DRP 4; DRP-4; DRP4; ULIP 4; ULIP-4; ULIP4; UNC33 like phosphoprotein 4; UNC33-like phosphoprotein 4

  • Target Background

    Enables filamin binding activity. Predicted to be involved in nervous system development. Predicted to be located in cytosol.

Inquire Recombinant Human Dihydropyrimidinase-related protein 4 (DPYSL4) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification